X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/20/2849358/0/en/RespireRx-Pharmaceuticals-Inc-Reports-Publication-of-Preclinical-Research-Results-Demonstrating-the-Ability-of-CX1739-its-Lead-Clinical-AMPAkine-to-Improve-Bladder-Function-After-S.html
https://www.globenewswire.com//news-release/2024/02/13/2828252/0/en/RespireRx-Pharmaceuticals-Inc-Reports-Preclinical-Pain-Relief-for-their-Non-Opioid-Lead-GABAkine.html
https://www.globenewswire.com//news-release/2024/01/22/2813052/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Appointment-of-Dr-Dariusz-Naziek-to-Its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/01/04/2804014/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Publication-of-a-Case-Report-in-which-KRM-II-81-Totally-Suppressed-Epileptiform-Activity-in-Brain-Tissue-Surgically-Removed-from-Epilept.html
https://www.globenewswire.com//news-release/2023/12/11/2793857/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Agreement-with-Ponto-Ventures-to-Drive-Business-Development-with-Will-Clodfelter-as-RespireRx-Part-Time-Senior-VP-of-Business-Development.html
https://www.globenewswire.com//news-release/2023/10/12/2759269/0/en/RespireRx-Pharmaceuticals-Inc-s-Subsidiary-ResolutionRx-Ltd-Enters-into-Master-Services-Agreement-for-Dronabinol-Manufacturing-and-Related-Services.html
https://www.globenewswire.com/news-release/2023/08/09/2721676/0/en/RespireRx-Pharmaceuticals-Inc-and-ResolutionRx-Ltd-Enter-into-Bilateral-Agreements-to-Establish-ResolutionRx-Ltd-as-an-Operating-Company.html
https://www.globenewswire.com/news-release/2023/05/24/2675238/0/en/ResolutionRx-Ltd-a-Subsidiary-of-RespireRx-Pharmaceuticals-Inc-Enters-into-Letter-of-Intent-with-Cantheon-Capital-for-the-Financing-of-Anticipated-Research-and-Development-Costs.html
https://www.globenewswire.com/news-release/2023/04/05/2641673/0/en/RespireRx-Pharmaceuticals-Inc-Establishes-Research-Collaboration-With-University-College-London-to-Study-the-Use-of-AMPAkines-for-the-Treatment-of-GRIA-Disorders.html
https://www.globenewswire.com/news-release/2023/04/03/2639578/0/en/RespireRx-Pharmaceuticals-Inc-Discloses-Novel-Structural-Analogs-of-its-GABAA-Receptor-Potentiator-KRM-II-81-with-Antiseizure-Efficacy-and-Antitremor-Effects-without-Sedation.html
Market Place
Share 
